Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | C7orf34 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | NOD2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | RCAN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | PLA2G6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | FAN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | HMSD | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | MTNR1A | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | RIF1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TNFRSF10B | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |